Real Chemistry Deepens Media and Technology Edge With Acquisition of Greater Than One

Real Chemistry, a global leader in AI-powered insights and marketing communications for the healthcare industry, announced the acquisition of Greater Than One, a distinguished healthcare-first agency known for its deep expertise in media, omnichannel strategy, and technology innovation. This strategic move enhances Real Chemistry’s end-to-end commercialization offerings, providing clients with greater precision, more robust analytics, and seamless engagement throughout the healthcare marketing lifecycle.

“Greater Than One brings deep media expertise, powerful proprietary tools and a culture that matches ours—focused, fast-moving and built to deliver results,” said Shankar Narayanan, CEO of Real Chemistry. “Together, we’ll help clients make smarter decisions and create more meaningful engagement with the audiences who matter most. We are rewriting the next chapter of what’s possible for healthcare marketing and adding Greater Than One to our team gives us even more firepower to drive this revolution.”

Driving Omnichannel Precision and Performance

Established nearly 25 years ago, Greater Than One has built a strong reputation for maximizing media and omnichannel performance through advanced data analytics, proprietary tools, and predictive modeling. These core technologies include:

  • Greater Reach – A predictive media planning engine that guides budget and channel allocation to achieve specific audience and engagement goals.
  • Greater Score – An advanced scoring solution that offers a unified view of HCP (healthcare professional) engagement across media and CRM channels, enabling smarter outreach and stronger campaign performance.
  • Greater Omni – A centralized omnichannel strategy and activation platform that provides real-time visibility into campaign performance. It features an Omnichannel Maturity Model that breaks down complex processes into clear, actionable stages—enabling more strategic, measurable, and effective execution.

Also Read: Comscore and HyphaMetrics Partner to Deliver Advanced Person-Level Audience Measurement

These capabilities will be integrated into Real Chemistry’s AI-driven platform, equipping clients with seamless access to unified planning, measurement, and omnichannel activation strategies—anchored in data-driven behavioral science.

In turn, clients of Greater Than One will gain access to Real Chemistry’s full spectrum of services, including AI-led strategy, creative development, medical communications, influencer engagement, integrated PR, and market access—offering a truly connected and comprehensive approach to healthcare marketing.

“This move multiplies our capability,” said Kevin Johnson, Group President and Managing Partner at Real Chemistry. “In a healthcare environment that demands more agility and precision than ever, Greater Than One brings the technology, talent, and focus to help us deliver faster decisions, smarter planning, and measurable impact where it matters most.”

A Unified Vision for Growth and Innovation

As part of the acquisition, Greater Than One will retain its brand identity under the Real Chemistry umbrella, continue to operate from its New York City headquarters, and maintain its remote-first working model. The agency’s full team will transition to Real Chemistry, continuing its client work while expanding access to broader capabilities.

“Finding a match like Real Chemistry, where our employees and clients will benefit, is exactly what we wanted for Greater Than One,” said Elizabeth Izard Apelles, President and CEO of Greater Than One. “Our shared belief that building innovative, client-first partnerships leads to impact and results is a powerful force behind this acquisition.”

The acquisition underscores Real Chemistry’s continued commitment to building a next-generation healthcare marketing organization—one that combines deep sector expertise, data science, and technology to solve today’s most complex healthcare challenges with speed, agility, and measurable results.

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More